Browsing Tag
US FDA
379 posts
Sun Pharma’s NDA for Deuruxolitinib garners FDA nod: A potential leap for alopecia areata patients
Sun Pharmaceutical Industries Ltd announced that the U.S. Food and Drug Administration (FDA) has officially accepted the New…
Zydus Lifesciences secures FDA nod for high-demand Sugammadex Injection
Zydus Lifesciences Limited, a formidable name in the pharmaceutical realm, proudly announces its final endorsement from the United…
Strides Pharma receives FDA approval for Icosapent Ethyl Capsules
Strides Pharma Science Limited (Strides) has achieved a significant milestone by announcing the United States Food & Drug…
Jardiance receives FDA approval to tackle kidney disease and cardiovascular risks
The U.S. Food and Drug Administration (FDA) has granted approval for Jardiance (empagliflozin) 10 mg tablets, a significant…
Eli Lilly receives FDA response letter for eczema treatment lebrikizumab
Eli Lilly and Company (NYSE: LLY) has announced a recent development regarding its biologic license application (BLA) for…
Lupin’s Nagpur Unit-1 gets FDA nod with VAI status
Global pharmaceutical powerhouse, Lupin Limited has announced the receipt of the Establishment Inspection Report (EIR) from the United…
Granules India gains FDA approval for Losartan-Hydrochlorothiazide Tablets
Granules India Limited proudly announced today that the United States Food & Drug Administration (US FDA) has granted…
Strides Pharma subsidiary gets FDA approval for Icosapent Ethyl Capsules
In a significant pharmaceutical breakthrough, Strides Pharma Science Limited announces that its wholly owned subsidiary, Strides Pharma Global…
Caplin Steriles gets FDA nod for Norepinephrine Bitartrate Injection
Caplin Steriles Limited, a subsidiary of Caplin Point Laboratories Limited has secured final approval from the United States…
Lantern Pharma gets FDA nod for LP-284 clinical trial in non-Hodgkin’s lymphoma
Lantern Pharma Inc. (NASDAQ: LTRN), a trailblazer in artificial intelligence (AI) and machine learning (ML) for targeted cancer…